BAYERI1 logo

Bayer S.A. (Peru) Stock Price

BVL:BAYERI1 Community·S/294.5m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 2 Fair Values set on narratives written by author

BAYERI1 Share Price Performance

S/0
0.00 (0.00%)
S/0
0.00 (0.00%)
Price S/0

BAYERI1 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet with proven track record.

3 Risks
2 Rewards

Bayer S.A. (Peru) Key Details

S/319.1m

Revenue

S/224.1m

Cost of Revenue

S/95.1m

Gross Profit

S/83.3m

Other Expenses

S/11.8m

Earnings

Last Reported Earnings
Mar 31, 2024
Next Reporting Earnings
n/a
0.80
29.79%
3.69%
0%
View Full Analysis

About BAYERI1

Founded
1947
Employees
n/a
CEO
Heiko Klaus Mussmann
WebsiteView website
www.bayer.com/es/co/andina-y-cac-home

Bayer S.A. (Peru) engages in the pharmaceuticals, consumer health, and crop science businesses in Peru. It operates through three segments: Crop Science, Pharmaceuticals, and Consumer Health. The company offers chemical crop protection products to control weeds; seeds and traits for corn, cotton, soybeans, oilseed rape/canola, rice, wheat, and other crops; biological and chemical products to protect crop plants against fungal diseases; biological and chemical products to protect crop plants from harmful insects and their larvae; vegetable seeds; digital applications for agriculture; products for consumer lawn and garden use and forestry, golf courses, railway tracks and landscape applications; biological and chemical seed treatment products to protect against fungal diseases and pests. It also provides prescription products for cardiology and women’s health, oncology, hematology, ophthalmology, medium-term cell and gene therapy, diagnostic imaging equipment, and contrast agents; and nonprescription OTC products for dermatology, nutritional supplements, digestive health, allergy, cough and cold, pain, and cardiovascular risk prevention. The company was incorporated in 1947 and is based in Lima, Peru. Bayer S.A. (Peru) operates as a subsidiary of Bayer Aktiengesellschaft.

Recent BAYERI1 News & Updates

Recent updates

No updates

Bayer S.A. (Peru) Competitors